DEA schedule
Is Actemra ACTPen a controlled substance?
Actemra ACTPen contains tocilizumab. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Actemra ACTPen (tocilizumab) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tocilizumab is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Actemra ACTPen?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | tocilizumab is not on the list |
Actemra ACTPen NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50242-143 | Actemra ACTPen | injection, solution | 162 mg/.9mL | Genentech, Inc. | None |
Questions
Is Actemra ACTPen a controlled substance?
No. Actemra ACTPen (tocilizumab) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tocilizumab is not on the DEA controlled substances list.
Is Actemra ACTPen a narcotic?
No. Actemra ACTPen (tocilizumab) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Interleukin-6 Receptor Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.